Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
16.4M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
3.15M
-
Shares change
-
-27.2K
-
Total reported value, excl. options
-
$57M
-
Value change
-
+$415K
-
Number of buys
-
12
-
Number of sells
-
-16
-
Price
-
$18.12
Significant Holders of ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) as of Q2 2025
41 filings reported holding ASMB - ASSEMBLY BIOSCIENCES, INC. - Common Stock as of Q2 2025.
ASSEMBLY BIOSCIENCES, INC. - Common Stock (ASMB) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.15M shares
of 16.4M outstanding shares and own 19.25% of the company stock.
Largest 10 shareholders include GILEAD SCIENCES, INC. (2.21M shares), VANGUARD GROUP INC (254K shares), B Group, Inc. (189K shares), RENAISSANCE TECHNOLOGIES LLC (108K shares), BlackRock, Inc. (89.7K shares), GEODE CAPITAL MANAGEMENT, LLC (51K shares), MONIMUS CAPITAL MANAGEMENT, LP (42.1K shares), CITADEL ADVISORS LLC (35.7K shares), NORTHERN TRUST CORP (28.1K shares), and FEDERATED HERMES, INC. (25.4K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.